- Home
- ABP vs ANTX Comparison
ABP vs ANTX Comparison
Compare ABP & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABP
- ANTX
- Stock Information
- Founded
- ABP N/A
- ANTX 2017
- Country
- ABP United States
- ANTX United States
- Employees
- ABP N/A
- ANTX N/A
- Industry
- ABP Biotechnology: Pharmaceutical Preparations
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- ABP Health Care
- ANTX Health Care
- Exchange
- ABP Nasdaq
- ANTX Nasdaq
- Market Cap
- ABP 29.8M
- ANTX 31.9M
- IPO Year
- ABP 2022
- ANTX 2022
- Fundamental
- Price
- ABP N/A
- ANTX $1.00
- Analyst Decision
- ABP
- ANTX Buy
- Analyst Count
- ABP 0
- ANTX 4
- Target Price
- ABP N/A
- ANTX $2.50
- AVG Volume (30 Days)
- ABP N/A
- ANTX 407.6K
- Earning Date
- ABP N/A
- ANTX 11-13-2024
- Dividend Yield
- ABP N/A
- ANTX N/A
- EPS Growth
- ABP N/A
- ANTX N/A
- EPS
- ABP N/A
- ANTX N/A
- Revenue
- ABP N/A
- ANTX N/A
- Revenue This Year
- ABP N/A
- ANTX N/A
- Revenue Next Year
- ABP N/A
- ANTX N/A
- P/E Ratio
- ABP N/A
- ANTX N/A
- Revenue Growth
- ABP N/A
- ANTX N/A
- 52 Week Low
- ABP N/A
- ANTX $0.87
- 52 Week High
- ABP N/A
- ANTX $22.22
- Technical
- Relative Strength Index (RSI)
- ABP N/A
- ANTX 30.50
- Support Level
- ABP N/A
- ANTX $0.99
- Resistance Level
- ABP N/A
- ANTX $1.14
- Average True Range (ATR)
- ABP 0.00
- ANTX 0.03
- MACD
- ABP 0.00
- ANTX -0.01
- Stochastic Oscillator
- ABP 0.00
- ANTX 6.67
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.